Abstract:Multidrug resistant (MDR) Klebsiella pneumoniae is a major cause of healthcare-associated infections around the world, with attendant high rates of morbidity and mortality. Progressive reduction in potency of antibiotics capable of treating MDR K. pneumoniae infections - including lung infection - as a consequence of escalating drug resistance provides the motivation to develop drug candidates targeting MDR K. pneumoniae. We recently reported degradable broad-spectrum antimicrobial guanidinium-functionalized polycarbonates with unique antimicrobial mechanism - membrane translocation followed by precipitation of cytosolic materials. These polymers exhibited high potency against bacteria with negligible toxicity. The polymer with ethyl spacer between the quanidinium group and the polymer backbone (pEt_20) showed excellent in vivo efficacy for treating MDR K. pneumoniae-caused peritonitis in mice. In this study, the structures of the polymers were optimized for the treatment of MDR Klebsiella pneumoniae lung infection. Specifically, in vitro antimicrobial activity and selectivity of guanidinium-functionalized polycarbonates containing the same number of guanidinium groups but of a shorter chain length and a structural analogue containing a thiouronium moiety as the pendent cationic group were evaluated. The polymers with optimal compositions and varying hydrophobicity were assessed against 25 clinically isolated K. pneumonia strains for antimicrobial activity and killing kinetics. The results showed that the polymers killed the bacteria more efficiently than clinically used antibiotics, and repeated use of the polymers did not cause drug resistance in K. pneumonia. Particularly, the polymer with butyl spacer (pBut_20) self-assembled into micelles at high concentrations, where the hydrophobic component was shielded in the micellar core, preventing interacting with mammalian cells. A subtle change in the hydrophobicity increased the antimicrobial activity while reducing in vivo toxicity. The in vivo efficacy studies showed that pBut_20 alleviated K. pneumonia lung infection without inducing damage to major organs. Taken together, pBut_20 is promising for treating MDR Klebsiella pneumoniae lung infection in vivo. STATEMENT OF SIGNIFICANCE: Multidrug resistant (MDR) Klebsiella pneumoniae is a major cause of healthcare-associated infections, with attendant high rates of morbidity and mortality. The progressive reduction in antibiotics capable of treating MDR K. pneumoniae infections - including lung infection - as a consequence of escalating drug resistance rates provides the motivation to develop drug candidates. In this study, we report a degradable guanidinium-functionalized polycarbonate with unexpected antimicrobial activity and selectivity towards MDR Klebsiella pneumoniae. A subtle change in polymer hydrophobicity increases antimicrobial activity while reducing in vivo toxicity due to self-assembly at high concentrations. The polymer with optimal composition alleviates Klebsiella pneumonia lung infection without inducing damage to major organs. The polymer is promising for treating MDR Klebsiella pneumoniae lung infection in vivo.

MGF‐Ct24E‐modified Piperazine Polymer: A Balance of Antimicrobial Activity and Cytotoxicity

Antibacterial Activity and Mechanism of Piperazine Polymer

An Antibacterial and Biocompatible Piperazine Polymer

Design and Synthesis of Novel Piperazine Derivatives with High Antibacterial Activity

Upcycling Poly(ethylene Terephthalate) Refuse to Advanced Therapeutics for the Treatment of Nosocomial and Mycobacterial Infections

Design, syntheses and evaluation of hemocompatible pegylated-antimicrobial polymers with well-controlled molecular structures.

Structural Superiority of Guanidinium-Rich, Four-Armed Copolypeptides: Role of Multiple Peptide-Membrane Interactions in Enhancing Bacterial Membrane Perturbation and Permeability.

Combination of Guanidinium and Quaternary Ammonium Polymers with Distinctive Antimicrobial Mechanisms Achieving a Synergistic Antimicrobial Effect.

Host Defense Peptide Mimicking Peptide Polymer Exerting Fast, Broad Spectrum, and Potent Activities Toward Clinically Isolated Multidrug-Resistant Bacteria.

Breaking or Following the Membrane-Targeting Mechanism: Exploring the Antibacterial Mechanism of Host Defense Peptide Mimicking Poly(2-Oxazoline)s

Peptide-mimicking Poly(2-Oxazoline) Displaying Potent Antibacterial and Antibiofilm Activities Against Multidrug-Resistant Gram-positive Pathogenic Bacteria

Degradable Antimicrobial Polycarbonates with Unexpected Activity and Selectivity for Treating Multidrug-Resistant Klebsiella Pneumoniae Lung Infection in Mice.

Intramolecular Cyclization of the Antimicrobial Peptide Polybia-MPI with Triazole Stapling: Influence on Stability and Bioactivity

Polymyxin B-inspired Non-Hemolytic Tyrocidine A Analogues with Significantly Enhanced Activity Against Gram-Negative Bacteria: How Cationicity Impacts Cell Specificity and Antibacterial Mechanism

Synthesis of Amphiphilic Cationic Polyesters and Their Antibacterial Activity

Design and Synthesis of Biocompatible, Hemocompatible, and Highly Selective Antimicrobial Cationic Peptidopolysaccharides Via Click Chemistry

Membrane Active Antimicrobial Activity and Molecular Dynamics Study of a Novel Cationic Antimicrobial Peptide Polybia-Mpi, from the Venom of Polybia Paulista

Improving the Hemocompatibility of Antimicrobial Peptidomimetics through Amphiphilicity Masking Using a Secondary Amphiphilic Polymer

Molecular Architecture and Charging Effects Enhance the in Vitro and in Vivo Performance of Multi‐Arm Antimicrobial Agents Based on Star‐Shaped Poly(l‐lysine)

Elaboration on the architecture of pH-sensitive surface charge-adaptive micelles with enhanced penetration and bactericidal activity in biofilms

Antimicrobial Anilinium Polymers: the Properties of Poly(n,n‐dimethylaminophenylene Methacrylamide) in Solution and As Coatings